https://www.selleckchem.com/products/stf-31.html
001), mean PAS (P less then .001), time to LVC (P less then .01), and need for thickening agents (P less then .001). Patients in the CT presented a less intense improvement of signs of impaired safety of swallow without significant changes in time to LVC. No differences between groups were observed for 1-year mortality (6.1%), respiratory infections (9.6%), nutritional and functional status, QoL, and hospital readmission rates (27.6%). No significant adverse events related to TES were observed. Conclusions and inferences. Transcutaneous
Like
Comment
Share
